← Evidence map

ArticleThe oncologist2021

An Illustrative Case of Combination Cabozantinib/Nivolumab for Progressive Metastatic Renal Cell Carcinoma (mRCC).

Chester Kao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2021
2022
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 33251710